Eli Lilly and Company reports new data point to significant itch relief for pediatric eczema Traders Union Source link
Phase 2 Data Highlight Roflumilast Cream in Infant AD Dermatology Times Source link
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities The Globe and Mail Source link
LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) BioSpace Source link